Neuropace, Inc. NPCE Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s accounts receivable?
- Neuropace, Inc. (NPCE) reported accounts receivable of $14.79M in Q1 2026.
- How has Neuropace, Inc.'s accounts receivable changed year-over-year?
- Neuropace, Inc.'s accounts receivable decreased by 4.2% year-over-year, from $15.44M to $14.79M.
- What is the long-term trend for Neuropace, Inc.'s accounts receivable?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s accounts receivable has grown at a 18.6% compound annual growth rate (CAGR), from $29.61M to $58.61M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.